መነሻ › የሳንባ መካከለኛ ሕዋስ በሽታዎች › ፍሎሪዳ
በፍሎሪዳ ለየሳንባ መካከለኛ ሕዋስ በሽታዎች የሚደረጉ ክሊኒካዊ ጥናቶች
ለየሳንባ መካከለኛ ሕዋስ በሽታዎች የሚደረጉ 24 ጥናቶች በፍሎሪዳ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በፍሎሪዳ ውስጥ ያሉ ከተሞች
Official study text (English)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Clinical Research Specialists LLC - Kissimmee, Kissimmee
- Lakeland Regional Medical Center - Lakeland, Lakeland
- Advanced Pulmonary Research Institute, Loxahatchee Groves
- እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Clinical Research Specialists LLC - Kissimmee, Kissimmee
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA017, Gainesville
- USA006, Naples
- USA026, St. Petersburg
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Florida, Gainesville
- New Access Research and Medical Services, Miami
- Eunix Clinical Research, Orlando
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT05798923A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Kissimmee
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT07816185A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Gainesville
- GSK Investigational Site, Naples
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06572384A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Jacksonville
- GSK Investigational Site, Miami
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Cleveland Clinic Florida, Weston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- AdventHealth Orlando, Orlando
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Tampa General Hospital, Tampa
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kissimmee
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Florida, Gainesville
- NCH Research Institute, Naples
- Advent Health Medical Group Advanced Lung Disease, Orlando
- እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06388421Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
- University of Miami Hospital and Clinics, Miami
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT07486869RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Florida, Jacksonville
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT06328777An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA006, Naples
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኦገስ 2026 · NCT07234032Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Florida, Gainesville
- University of South Florida, Tampa
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 21 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Mayo Clinic of Florida, Jacksonville
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT07175038Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- University of South Florida, Tampa
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 4 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Ascension Medical Group St. Vincent's Lung Institute, Jacksonville
- Mayo Clinic, Jacksonville
- TGH/USF Center for Advanced Lung Disease and Lung Transplant, Tampa
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT05943535An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Advent Health, Orlando
- Tampa General Hospital Center of Research Excellence, Tampa
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ26 ጁን 2026 · NCT06129240Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
- Mayo Clinic in Florida, Jacksonville
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ማርች 2026 · NCT06751069Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
- Maule Stem Cell Research Institute, Venice
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጃንዩ 2026 · NCT07372989Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Florida Lung Asthma and Sleep Specialist, Celebration
- Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando, Orlando
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኖቬም 2025 · NCT05975983Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Miami
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ሜይ 2025 · NCT05892614ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።